PATENT CLAIM ANALYSIS

Application Number: 16147153
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.

Claim (Index 57):
A pharmaceutical composition for oral administration to a subject born with single ventricle heart disease who has undergone Fontan surgery for improving, maintaining or reducing the rate of decline in a clinically relevant measurement that is indicative of the subject's health following the Fontan surgery or for increasing the likelihood of improving, maintaining or reducing the rate of decline in the clinically relevant measurement that is indicative of the subject's health following the Fontan surgery, said pharmaceutical composition comprising:\n udenafil, or a pharmaceutically acceptable salt thereof, in a therapeutically effective dose; and a pharmaceutically acceptable excipient, for improving, maintaining or reducing the rate of decline in a clinically relevant measurement that is indicative of the subject's health following the Fontan surgery or for increasing the likelihood of improving, maintaining or reducing the rate of decline in the clinically relevant measurement that is indicative of the subject's health following the Fontan surgery in the subject; wherein, the subject is a human, whose age ranges from about 12 to under about 18 years of age or older; wherein, the therapeutically effective dose of udenafil, or a pharmaceutically acceptable salt thereof, is at least about 125 mg; wherein, the pharmaceutical composition is a solid or semi-solid oral pharmaceutical composition; wherein, the solid or semi-solid oral pharmaceutical composition is selected from a group of solid or semi-solid oral pharmaceutical compositions consisting of a tablet, a capsule, a gel, a pill, a suspension and a powder; and wherein, the clinically relevant measurement is exercise capacity.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 97.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15887523', '14788211', '15197209', '14079548', '15671653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256893397645952
- 35 USC 102 Novelty (BERT): 0.6434501852244755
- Combined Prediction Score: 0.7174654243105832
- Mean Citation Score: 447.53735599999993
- Max Citation Score: 837.41754
- Similarity Product: 554.7909371186901

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test